The coronavirus pandemic has reinforced the importance of investing in population health domestically and globally, and of public-private collaboration in innovation for health goals–from technology for healthy aging to poverty alleviation and addressing other social determinants of health disparities. China, as the first health system to experience the devastation of COVID-19 and to rebound from pandemic control, offers lessons relevant beyond its borders. What can we draw from China’s progress on healthcare development and its aims for innovation and public-private collaboration? In this webinar, Chinese practitioners and experts from academia and government will share their views on post-pandemic health policy and draw lessons for cooperation in global health. Scholars who have worked in and studied both the PRC and US health systems will discuss the challenges facing both—from strengthening risk protection and aligning incentives for quality improvement, to promoting goals articulated in the US’ 5th iteration of population health ‘ten-year plans’ (“Healthy People 2030”) and the PRC’s more recent “Healthy China 2030” and broader 14th Five Year Plan. What will it take to implement these ambitious goals? What is the linkage between health and China’s foreign policy objectives and its place in the world?
Dr. Ying Cao, China Country Director, Vital Strategies’ Resolve to Save Lives Global Health Initiatives
Dr. Gordon Liu, Professor, Peking University
Dr. Liang Xiaofeng, Executive Vice President and Secretary General of the Chinese Preventive Medicine Association (To be confirmed)